← Eichor
Condition: Bacterial Conjunctivitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Bacterial Conjunctivitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Phase 3 · 38 location(s) · Baxis Pharmaceuticals, Inc. · NCT06911424
Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
Phase N/A · 2 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT04198740
Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye
Phase N/A · 1 location(s) · Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07634913
Safety and Efficacy of SUM-191 for Patients With Bacterial Conjunctivitis
Phase 1/Phase 2 · 1 location(s) · Senju USA, Inc. · NCT07565103
RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)
NA · 2 location(s) · University of North Carolina, Chapel Hill · NCT07322302
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.